Mode
Text Size
Log in / Sign up
N/A N=68 Randomized Triple-blind Treatment

Seroma Formation After Modified Radical Mastectomy With Flap Fixation Technique in Breast Cancer Patients

Breast-cancer

Enrolled (actual)
68
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcome: Primary: Seroma Formation — 54.27; 59.56; 102.21; 117.94 ml — p=<0.005

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Flap fixation technique (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Nakhon Phanom Hospital
Primary completion
Jun 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Seroma Formation
54.27; 59.56; 102.21; 117.94; 85.00; 94.24 <0.005 sig
SECONDARY
Complication After Surgery 1. Wound Infection 2. Joint Stiffness 3. Visit Before the Appointment Date
0; 2; 3; 2; 0; 6 <0.05 sig

Summary

The goal of this clinical trial is to evaluate the effectiveness of mastectomy flap fixation in breast cancer patients. The main questions it aims to answer are: - To compare seroma formation after mastectomy flap fixation with conventional surgery in breast cancer patients Participants will be randomly divided into 2 groups, 1. Mastectomy flap fixation 2. Conventional surgery with non flap fixation. Researchers will record the amount and color of drainage fluid, patient and tumor characteristics, and operative related factor after surgery. Researchers will compare with conventional surgery to see if seroma formation, and wound infection.

Eligibility Criteria

Inclusion Criteria

  • Breast cancer (CA Breast) patients plan to modified radical mastectomy
  • Operable case, or Resectable case

Exclusion Criteria

  • Having medical bleeding tendency e.g., Idiopathic Thrombocytopenia (ITP), leukemia, other bleeding disorder
  • Immunocompromised e.g., HIV, Systemic Lupus Erythematosus (SLE), liver cirrhosis, immunosuppressive drug
  • Other modified radical mastectomy whom required reconstruction, flap coverage e.g., Transverse Rectus Abdominis Musculocutaneous (TRAM) flap, Latissimus Dorsi (LD) flap
  • Past history of mammoplasty, augmentation
  • Past history of axillary lymphatic system operation
  • Pregnant women
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06243796). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search